VistaGen Therapeutics, Inc.
VTGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $126,910 | $63,861 | $76,780 | $90,600 |
| - Cash | $62,786 | $48,985 | $67,131 | $74,715 |
| + Debt | $1,207 | $2,356 | $1,509 | $1,713 |
| Enterprise Value | $65,331 | $17,232 | $11,158 | $17,598 |
| Revenue | $258 | $244 | -$15 | $234 |
| % Growth | 5.7% | 1,726.7% | -106.4% | – |
| Gross Profit | $258 | $75 | -$15 | $234 |
| % Margin | 100% | 30.7% | 100% | 100% |
| EBITDA | -$19,232 | -$14,926 | -$14,329 | -$14,959 |
| % Margin | -7,454.3% | -6,117.2% | 95,526.7% | -6,392.7% |
| Net Income | -$19,417 | -$15,095 | -$13,635 | -$14,089 |
| % Margin | -7,526% | -6,186.5% | 90,900% | -6,020.9% |
| EPS Diluted | -0.54 | -0.47 | -0.44 | -0.46 |
| % Growth | -14.9% | -6.8% | 4.3% | – |
| Operating Cash Flow | -$13,759 | -$18,846 | -$10,062 | -$10,280 |
| Capital Expenditures | -$60 | $0 | -$88 | $0 |
| Free Cash Flow | -$13,819 | -$18,846 | -$10,150 | -$10,280 |